318 related articles for article (PubMed ID: 26035394)
21. Impaired excitation-contraction coupling in muscle fibres from the dynamin2
Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V
J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728
[TBL] [Abstract][Full Text] [Related]
22. Sarcolipin and phospholamban inhibit the calcium pump by populating a similar metal ion-free intermediate state.
Espinoza-Fonseca LM; Autry JM; Thomas DD
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):37-41. PubMed ID: 25983321
[TBL] [Abstract][Full Text] [Related]
23. Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban.
Asahi M; Sugita Y; Kurzydlowski K; De Leon S; Tada M; Toyoshima C; MacLennan DH
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5040-5. PubMed ID: 12692302
[TBL] [Abstract][Full Text] [Related]
24. The regulation of SERCA-type pumps by phospholamban and sarcolipin.
MacLennan DH; Asahi M; Tupling AR
Ann N Y Acad Sci; 2003 Apr; 986():472-80. PubMed ID: 12763867
[TBL] [Abstract][Full Text] [Related]
25. Phospholamban degradation is induced by phosphorylation-mediated ubiquitination and inhibited by interaction with cardiac type Sarco(endo)plasmic reticulum Ca(2+)-ATPase.
Nakagawa T; Yokoe S; Asahi M
Biochem Biophys Res Commun; 2016 Apr; 472(3):523-30. PubMed ID: 26966065
[TBL] [Abstract][Full Text] [Related]
26. Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight.
Braun JL; Geromella MS; Hamstra SI; Messner HN; Fajardo VA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769190
[TBL] [Abstract][Full Text] [Related]
27. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
28. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
[TBL] [Abstract][Full Text] [Related]
29. SERCA2a tyrosine nitration coincides with impairments in maximal SERCA activity in left ventricles from tafazzin-deficient mice.
Braun JL; Hamstra SI; Messner HN; Fajardo VA
Physiol Rep; 2019 Aug; 7(16):e14215. PubMed ID: 31444868
[TBL] [Abstract][Full Text] [Related]
30. Rheostatic Regulation of the SERCA/Phospholamban Membrane Protein Complex Using Non-Coding RNA and Single-Stranded DNA oligonucleotides.
Soller KJ; Verardi R; Jing M; Abrol N; Yang J; Walsh N; Vostrikov VV; Robia SL; Bowser MT; Veglia G
Sci Rep; 2015 Aug; 5():13000. PubMed ID: 26292938
[TBL] [Abstract][Full Text] [Related]
31. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
[TBL] [Abstract][Full Text] [Related]
32. Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy.
Fraysse B; Guicheney P; Bitoun M
Biol Open; 2016 Nov; 5(11):1691-1696. PubMed ID: 27870637
[TBL] [Abstract][Full Text] [Related]
33. [The dynamin-2-gene related centronuclear myopathy].
Bitoun M
Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
[TBL] [Abstract][Full Text] [Related]
34. Reduced sarcoplasmic reticulum Ca
Qaisar R; Qayum M; Muhammad T
Life Sci; 2021 May; 273():119296. PubMed ID: 33675897
[TBL] [Abstract][Full Text] [Related]
35. Effects of sarcolipin deletion on skeletal muscle adaptive responses to functional overload and unload.
Fajardo VA; Rietze BA; Chambers PJ; Bellissimo C; Bombardier E; Quadrilatero J; Tupling AR
Am J Physiol Cell Physiol; 2017 Aug; 313(2):C154-C161. PubMed ID: 28592414
[TBL] [Abstract][Full Text] [Related]
36. Interaction sites among phospholamban, sarcolipin, and the sarco(endo)plasmic reticulum Ca(2+)-ATPase.
Morita T; Hussain D; Asahi M; Tsuda T; Kurzydlowski K; Toyoshima C; Maclennan DH
Biochem Biophys Res Commun; 2008 Apr; 369(1):188-94. PubMed ID: 18053795
[TBL] [Abstract][Full Text] [Related]
37. Sarco(endo)plasmic reticulum calcium ATPase (SERCA) inhibition by sarcolipin is encoded in its luminal tail.
Gorski PA; Glaves JP; Vangheluwe P; Young HS
J Biol Chem; 2013 Mar; 288(12):8456-8467. PubMed ID: 23362265
[TBL] [Abstract][Full Text] [Related]
38. A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.
James NG; Digman MA; Ross JA; Barylko B; Wang L; Li J; Chen Y; Mueller JD; Gratton E; Albanesi JP; Jameson DM
Biochim Biophys Acta; 2014 Jan; 1840(1):315-21. PubMed ID: 24016602
[TBL] [Abstract][Full Text] [Related]
39. Adult centronuclear myopathies: A hospital-based study.
Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
[TBL] [Abstract][Full Text] [Related]
40. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
